Isotopen Technologien München raised €188m in a round led by Temasek, joined by BlackRock, Qatar Investment Authority, Athos, and Carbyne. Biotech Health services Pharma Investments 01 June 2024 Share:
Round value (USD): 203.04m Round investors: Athos Service BlackRock Temasek Qatar Investment Authority Carbyne Equity Partners Company: Isotopen Technologien München Industry: Biotech Health services Pharma
CatalYm raised $150m in Series D funding co-led by Canaan Partners and Bioqube Ventures Biotech Health services Manufacturing Investments 04 July 2024
Cardior Pharmaceuticals was acquired by Novo Nordisk for 1.025 billion Euro Biotech Health services Pharma Secondary 21 March 2024
Tubulis raised €128m in a Series B extension backed by EQT Life Sciences and Nextech Invest Biotech Health services Investments 03 March 2024